rs1553700699
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000335.5(SCN5A):c.2466G>A(p.Trp822*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Consequence
SCN5A
NM_000335.5 stop_gained
NM_000335.5 stop_gained
Scores
5
1
1
Clinical Significance
Conservation
PhyloP100: 7.91
Genes affected
SCN5A (HGNC:10593): (sodium voltage-gated channel alpha subunit 5) The protein encoded by this gene is an integral membrane protein and tetrodotoxin-resistant voltage-gated sodium channel subunit. This protein is found primarily in cardiac muscle and is responsible for the initial upstroke of the action potential in an electrocardiogram. Defects in this gene have been associated with long QT syndrome type 3 (LQT3), atrial fibrillation, cardiomyopathy, and Brugada syndrome 1, all autosomal dominant cardiac diseases. Alternative splicing results in several transcript variants encoding different isoforms. [provided by RefSeq, May 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 3-38586012-C-T is Pathogenic according to our data. Variant chr3-38586012-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 505895.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr3-38586012-C-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN5A | NM_001099404.2 | c.2466G>A | p.Trp822* | stop_gained | 16/28 | ENST00000413689.6 | NP_001092874.1 | |
SCN5A | NM_000335.5 | c.2466G>A | p.Trp822* | stop_gained | 16/28 | ENST00000423572.7 | NP_000326.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN5A | ENST00000413689.6 | c.2466G>A | p.Trp822* | stop_gained | 16/28 | 5 | NM_001099404.2 | ENSP00000410257.1 | ||
SCN5A | ENST00000423572.7 | c.2466G>A | p.Trp822* | stop_gained | 16/28 | 1 | NM_000335.5 | ENSP00000398266.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 36
GnomAD4 exome
Cov.:
36
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Brugada syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Dec 13, 2017 | The p.Trp822X variant in SCN5A has been reported in a pair of male monozygotic t wins who died from sudden infant death syndrome (SIDS; Turillazzi 2008). This va riant was absent from large population studies. This same amino acid change (p.T rp822X) from a different cDNA change (c.2465G>A) has also been identified in one individual with Brugada syndrome and segregated with disease in one affected re lative (Keller 2005). In vitro functional studies provide some evidence that the p.Trp822X variant may impact protein function (Keller 2005, Turillazzi 2008). T his nonsense variant leads to a premature termination codon at position 822, whi ch is predicted to lead to a truncated or absent protein. Loss of function varia nts in SCN5A are typically associated with Brugada syndrome although overlapping presentations including other SCN5A related phenotypes (Long QT syndrome) have been described (Remme 2013). In summary, this variant meets criteria to be class ified as pathogenic for Brugada syndrome in an autosomal dominant manner based u pon impact to the protein, functional evidence, and absence from controls. ACMG/ AMP Criteria applied: PVS1, PM2, PP3_Supporting (Richards 2015). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at